Boyd Steven
Insider CIK 1706140 · PTIE 10% owner · ONTX 10% owner · BPTH 10% owner · ALIM 10% owner · RSLS 10% owner · EYEG Director, 10% owner · TTPH Director, 10% owner · AYTU Director, 10% owner · INNV 10% owner · DFRG Director, 10% owner · RSLS 10% owner · CERC Director, 10% owner · VLRX 10% owner · TENX Director, 10% owner · VXRT Director, 10% owner · AMAG 10% owner · VICL 10% owner · CTDH 10% owner · ACHV 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVTX Avalo Therapeutics, Inc. | S Sale | 2023-06-27 | 2023-06-28 | 937,404 | $0.52 | $487.5K | 731,458 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2023-06-26 | 2023-06-28 | 2,746,138 | $0.61 | $1.68M | 1,668,862 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy deriv | 2023-02-07 | 2023-02-09 | 450,000 | — | $0 | 450,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2023-02-07 | 2023-02-09 | 450,000 | — | $0 | 4,415,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | L Small acq | 2023-02-03 | 2023-02-09 | 334 | $3.95 | $1.3K | 3,965,000 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | D To issuer deriv | 2022-05-18 | 2022-05-19 | 2,360,313 | — | $0 | 0 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | D To issuer deriv | 2022-05-18 | 2022-05-19 | 4,773,269 | — | $0 | 0 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2022-05-18 | 2022-05-19 | 10,596,027 | — | $0 | 10,596,027 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | D To issuer deriv | 2022-05-18 | 2022-05-19 | 3,175,924 | — | $0 | 0 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2022-05-18 | 2022-05-19 | 3,175,924 | — | $0 | 3,175,924 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | D To issuer deriv | 2022-05-18 | 2022-05-19 | 4,607,692 | — | $0 | 0 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2022-05-18 | 2022-05-19 | 10,596,027 | — | $0 | 10,596,027 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2022-05-18 | 2022-05-19 | 4,607,692 | — | $0 | 4,607,692 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2022-05-18 | 2022-05-19 | 4,773,269 | — | $0 | 4,773,269 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2022-05-18 | 2022-05-19 | 2,360,313 | — | $0 | 2,360,313 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | D To issuer deriv | 2022-05-18 | 2022-05-19 | 2,072,538 | — | $0 | 0 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2022-05-18 | 2022-05-19 | 2,072,538 | — | $0 | 2,072,538 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-03-14 | 2022-03-14 | 100,000 | $0.65 | $65.0K | 47,576,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-03-11 | 2022-03-14 | 100,000 | $0.69 | $69.0K | 47,476,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-03-10 | 2022-03-14 | 26,000 | $0.70 | $18.2K | 47,376,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-03-07 | 2022-03-07 | 325,000 | $0.66 | $214.5K | 47,350,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-03-04 | 2022-03-07 | 135,000 | $0.70 | $94.5K | 47,025,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-03-03 | 2022-03-07 | 50,000 | $0.71 | $35.5K | 46,890,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-02-25 | 2022-02-28 | 40,000 | $0.79 | $31.6K | 46,840,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-02-24 | 2022-02-28 | 100,000 | $0.80 | $80.0K | 46,800,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-02-22 | 2022-02-22 | 83,000 | $0.77 | $63.9K | 46,700,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-02-18 | 2022-02-22 | 55,000 | $0.82 | $45.1K | 46,617,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-02-17 | 2022-02-22 | 150,000 | $0.82 | $123.0K | 46,562,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-01-20 | 2022-01-20 | 12,000 | $0.85 | $10.2K | 46,412,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-01-19 | 2022-01-20 | 93,700 | $0.88 | $82.5K | 46,400,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-01-18 | 2022-01-20 | 206,300 | $0.88 | $181.5K | 46,306,300 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-01-14 | 2022-01-14 | 85,000 | $0.93 | $79.0K | 46,100,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-01-13 | 2022-01-14 | 312,700 | $1.00 | $312.7K | 46,015,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-01-12 | 2022-01-14 | 57,300 | $1.04 | $59.6K | 45,702,300 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-01-11 | 2022-01-11 | 16,003 | $0.96 | $15.4K | 45,645,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-01-10 | 2022-01-11 | 491,097 | $0.99 | $486.2K | 45,628,997 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2022-01-07 | 2022-01-11 | 137,900 | $1.04 | $143.4K | 45,137,900 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2021-09-17 | 2021-09-17 | 5,454,545 | $2.20 | $12.00M | 45,000,000 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2021-09-16 | 2021-09-17 | 150,000 | $2.28 | $342.0K | 39,545,455 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | P Buy | 2021-09-15 | 2021-09-17 | 95,455 | $2.26 | $215.7K | 39,395,455 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2021-08-18 | 2021-08-18 | 20,000 | $2.78 | $55.6K | 39,300,000 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2021-08-16 | 2021-08-18 | 30,000 | $2.75 | $82.5K | 39,280,000 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2021-08-06 | 2021-08-06 | 25,000 | $2.83 | $70.8K | 39,250,000 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2021-08-05 | 2021-08-06 | 25,000 | $2.77 | $69.3K | 39,225,000 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2021-08-04 | 2021-08-06 | 100,000 | $2.69 | $269.0K | 39,200,000 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | S Sale | 2021-08-02 | 2021-08-03 | 192,775 | $2.40 | $462.7K | 785,000 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | S Sale | 2021-07-30 | 2021-08-03 | 68,188 | $2.69 | $183.4K | 977,775 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | S Sale | 2021-07-29 | 2021-07-29 | 400,000 | $3.00 | $1.20M | 1,045,963 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | S Sale | 2021-07-28 | 2021-07-29 | 375,443 | $3.28 | $1.23M | 1,445,963 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | C Conversion deriv | 2021-07-27 | 2021-07-29 | 4,092 | — | $0 | 0 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | C Conversion | 2021-07-27 | 2021-07-29 | 852,500 | $4.80 | $4.09M | 4,199,101 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | S Sale | 2021-07-27 | 2021-07-29 | 73,101 | $7.06 | $516.1K | 4,126,000 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | S Sale | 2021-07-27 | 2021-07-29 | 461,797 | $6.45 | $2.98M | 3,664,203 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | S Sale | 2021-07-27 | 2021-07-29 | 729,114 | $5.44 | $3.97M | 2,935,089 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | S Sale | 2021-07-27 | 2021-07-29 | 581,614 | $3.80 | $2.21M | 1,821,406 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | S Sale | 2021-07-27 | 2021-07-29 | 532,069 | $4.59 | $2.44M | 2,403,020 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2021-07-08 | 2021-07-09 | 4,773,269 | — | $0 | 4,773,269 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | A Award deriv | 2021-07-08 | 2021-07-09 | 4,773,269 | — | $0 | 4,773,269 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise deriv | 2021-06-28 | 2021-06-29 | 1,479,713 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise deriv | 2021-06-28 | 2021-06-29 | 0 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise deriv | 2021-06-28 | 2021-06-29 | 0 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise deriv | 2021-06-28 | 2021-06-29 | 1,479,713 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise deriv | 2021-06-28 | 2021-06-29 | 0 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise deriv | 2021-06-28 | 2021-06-29 | 676,440 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise deriv | 2021-06-28 | 2021-06-29 | 0 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise deriv | 2021-06-28 | 2021-06-29 | 676,440 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise deriv | 2021-06-28 | 2021-06-29 | 0 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise deriv | 2021-06-28 | 2021-06-29 | 2,254,800 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise deriv | 2021-06-28 | 2021-06-29 | 0 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise deriv | 2021-06-28 | 2021-06-29 | 563,700 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise | 2021-06-28 | 2021-06-29 | 0 | — | $0 | 1,572,253 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise | 2021-06-28 | 2021-06-29 | 1,479,713 | — | $0 | 1,572,253 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise | 2021-06-28 | 2021-06-29 | 676,440 | — | $0 | 3,728,406 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise | 2021-06-28 | 2021-06-29 | 0 | — | $0 | 3,051,966 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise | 2021-06-28 | 2021-06-29 | 0 | — | $0 | 7,223,346 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise | 2021-06-28 | 2021-06-29 | 563,700 | — | $0 | 7,223,346 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise | 2021-06-28 | 2021-06-29 | 0 | — | $0 | 6,659,646 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise | 2021-06-28 | 2021-06-29 | 2,254,800 | — | $0 | 6,659,646 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise | 2021-06-28 | 2021-06-29 | 0 | — | $0 | 4,404,846 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise | 2021-06-28 | 2021-06-29 | 676,440 | — | $0 | 4,404,846 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise | 2021-06-28 | 2021-06-29 | 0 | — | $0 | 3,728,406 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | X Exercise | 2021-06-28 | 2021-06-29 | 1,479,713 | — | $0 | 3,051,966 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | S Sale | 2021-06-18 | 2021-06-22 | 685,583 | $5.48 | $3.76M | 105,873 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | S Sale | 2021-06-18 | 2021-06-22 | 0 | — | $0 | 105,873 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | S Sale | 2021-06-17 | 2021-06-22 | 0 | — | $0 | 872,822 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | S Sale | 2021-06-17 | 2021-06-22 | 1,024,844 | $6.20 | $6.35M | 872,822 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | S Sale | 2021-06-17 | 2021-06-22 | 81,366 | $7.13 | $580.1K | 791,456 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | S Sale | 2021-06-17 | 2021-06-22 | 0 | — | $0 | 791,456 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | S Sale | 2021-06-16 | 2021-06-22 | 0 | — | $0 | 1,897,666 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | S Sale | 2021-06-16 | 2021-06-22 | 50,040 | $8.52 | $426.3K | 1,897,666 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | S Sale | 2021-06-16 | 2021-06-22 | 0 | — | $0 | 1,947,706 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | S Sale | 2021-06-16 | 2021-06-22 | 73,591 | $7.92 | $582.8K | 1,947,706 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | S Sale | 2021-06-16 | 2021-06-22 | 0 | — | $0 | 2,021,297 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | S Sale | 2021-06-16 | 2021-06-22 | 388,045 | $6.52 | $2.53M | 2,021,297 | SEC↗ |
| RSLS ReShape Weightloss Inc. | J Other deriv | 2021-06-15 | 2021-06-22 | 0 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Weightloss Inc. | J Other deriv | 2021-06-15 | 2021-06-22 | 1,200,000 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Weightloss Inc. | J Other deriv | 2021-06-15 | 2021-06-22 | 0 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Weightloss Inc. | J Other deriv | 2021-06-15 | 2021-06-22 | 2,625,000 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Weightloss Inc. | J Other deriv | 2021-06-15 | 2021-06-22 | 0 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Weightloss Inc. | J Other deriv | 2021-06-15 | 2021-06-22 | 2,625,000 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Weightloss Inc. | J Other deriv | 2021-06-15 | 2021-06-22 | 4,000,000 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Weightloss Inc. | J Other deriv | 2021-06-15 | 2021-06-22 | 1,000,000 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Weightloss Inc. | J Other deriv | 2021-06-15 | 2021-06-22 | 1,200,000 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Weightloss Inc. | J Other deriv | 2021-06-15 | 2021-06-22 | 0 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Weightloss Inc. | J Other deriv | 2021-06-15 | 2021-06-22 | 0 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Weightloss Inc. | J Other deriv | 2021-06-15 | 2021-06-22 | 0 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Weightloss Inc. | J Other | 2021-06-15 | 2021-06-22 | 0 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Weightloss Inc. | J Other | 2021-06-15 | 2021-06-22 | 5,330,277 | — | $0 | 0 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2021-05-18 | 2021-05-18 | 22,000 | $2.33 | $51.3K | 39,100,000 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2021-05-18 | 2021-05-18 | 0 | — | $0 | 39,100,000 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2021-05-17 | 2021-05-18 | 30,000 | $2.20 | $66.0K | 39,078,000 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2021-05-17 | 2021-05-18 | 0 | — | $0 | 39,078,000 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2021-05-14 | 2021-05-18 | 0 | — | $0 | 39,048,000 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2021-05-14 | 2021-05-18 | 128,000 | $2.15 | $275.2K | 39,048,000 | SEC↗ |
| CERC Cerecor Inc. | C Conversion deriv | 2021-04-15 | 2021-04-19 | 0 | — | $0 | 0 | SEC↗ |
| CERC Cerecor Inc. | C Conversion deriv | 2021-04-15 | 2021-04-19 | 1,257,143 | — | $0 | 0 | SEC↗ |
| CERC Cerecor Inc. | C Conversion | 2021-04-15 | 2021-04-19 | 0 | — | $0 | 38,920,000 | SEC↗ |
| CERC Cerecor Inc. | C Conversion | 2021-04-15 | 2021-04-19 | 6,285,715 | $2.00 | $12.57M | 38,920,000 | SEC↗ |
| AYTU AYTU BIOPHARMA, INC | J Other | 2021-03-29 | 2021-05-10 | 2,085 | — | $0 | 1,342,378 | SEC↗ |
| AYTU AYTU BIOPHARMA, INC | J Other | 2021-03-29 | 2021-05-10 | 0 | — | $0 | 1,342,378 | SEC↗ |
| AYTU AYTU BIOPHARMA, INC | J Other | 2021-03-20 | 2021-05-10 | 0 | — | $0 | 1,340,293 | SEC↗ |
| AYTU AYTU BIOPHARMA, INC | J Other | 2021-03-20 | 2021-05-10 | 6,959 | — | $0 | 1,340,293 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2021-01-08 | 2021-01-12 | 2,500,000 | $2.60 | $6.50M | 32,634,285 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2021-01-08 | 2021-01-12 | 0 | — | $0 | 32,634,285 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | P Buy deriv | 2021-01-06 | 2021-01-08 | 1,531,101 | — | $0 | 1,531,101 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | P Buy deriv | 2021-01-06 | 2021-01-08 | 0 | — | $0 | 1,531,101 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | P Buy | 2021-01-06 | 2021-01-08 | 1,531,101 | $5.23 | $8.01M | 3,346,601 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | P Buy | 2021-01-06 | 2021-01-08 | 0 | — | $0 | 3,346,601 | SEC↗ |
| AYTU AYTU BIOSCIENCE, INC | P Buy | 2020-12-11 | 2020-12-15 | 0 | — | $0 | 1,333,334 | SEC↗ |
| AYTU AYTU BIOSCIENCE, INC | P Buy | 2020-12-11 | 2020-12-15 | 1,333,334 | $6.00 | $8.00M | 1,333,334 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-12-04 | 2020-12-04 | 0 | — | $0 | 5,330,277 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-12-04 | 2020-12-04 | 5,400 | $4.13 | $22.3K | 5,330,277 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-12-03 | 2020-12-07 | 20,000 | $2.44 | $48.8K | 30,134,285 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-12-03 | 2020-12-07 | 0 | — | $0 | 30,134,285 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-12-02 | 2020-12-04 | 0 | — | $0 | 5,324,877 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-12-02 | 2020-12-04 | 1,000 | $4.31 | $4.3K | 5,324,877 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-11-25 | 2020-11-25 | 0 | — | $0 | 30,114,285 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-11-25 | 2020-11-25 | 15,000 | $2.39 | $35.9K | 30,114,285 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-11-24 | 2020-11-25 | 0 | — | $0 | 30,099,285 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-11-24 | 2020-11-25 | 47,733 | $2.40 | $114.6K | 30,099,285 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-11-23 | 2020-11-25 | 0 | — | $0 | 30,051,552 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-11-23 | 2020-11-25 | 37,267 | $2.32 | $86.5K | 30,051,552 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-11-17 | 2020-11-17 | 0 | — | $0 | 5,323,877 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-11-17 | 2020-11-17 | 187 | $4.50 | $842 | 5,323,877 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-11-13 | 2020-11-17 | 790 | $4.14 | $3.3K | 5,323,690 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-11-13 | 2020-11-17 | 0 | — | $0 | 5,323,690 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-11-10 | 2020-11-12 | 2,400 | $3.58 | $8.6K | 5,322,900 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-11-10 | 2020-11-12 | 0 | — | $0 | 5,322,900 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-11-02 | 2020-11-04 | 3,100 | $3.56 | $11.0K | 5,320,500 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-11-02 | 2020-11-04 | 0 | — | $0 | 5,320,500 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-30 | 2020-10-01 | 5,500 | $0.13 | $715 | 15,795,769 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-30 | 2020-10-01 | 0 | — | $0 | 15,795,769 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-29 | 2020-10-01 | 0 | — | $0 | 15,801,269 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-29 | 2020-10-01 | 5,000 | $0.14 | $700 | 15,801,269 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-28 | 2020-09-28 | 0 | — | $0 | 15,806,269 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-28 | 2020-09-28 | 4,966 | $0.13 | $646 | 15,806,269 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-24 | 2020-09-28 | 38,257 | $0.13 | $5.0K | 15,811,235 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-24 | 2020-09-28 | 0 | — | $0 | 15,811,235 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-23 | 2020-09-23 | 0 | — | $0 | 15,849,492 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-23 | 2020-09-23 | 50,000 | $0.14 | $7.0K | 15,849,492 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-09-23 | 2020-09-25 | 1,000 | $3.91 | $3.9K | 5,316,400 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-09-23 | 2020-09-25 | 0 | — | $0 | 5,316,400 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-09-23 | 2020-09-25 | 1,000 | $4.23 | $4.2K | 5,317,400 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-09-23 | 2020-09-25 | 0 | — | $0 | 5,317,400 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-09-22 | 2020-09-22 | 1,000 | $4.77 | $4.8K | 5,315,400 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-09-22 | 2020-09-22 | 0 | — | $0 | 5,315,400 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-22 | 2020-09-23 | 0 | — | $0 | 15,899,492 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-22 | 2020-09-23 | 17,000 | $0.15 | $2.5K | 15,899,492 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-09-21 | 2020-09-22 | 300 | $4.45 | $1.3K | 5,314,400 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-09-21 | 2020-09-22 | 0 | — | $0 | 5,314,400 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-21 | 2020-09-23 | 0 | — | $0 | 15,916,492 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-21 | 2020-09-23 | 100,000 | $0.15 | $15.0K | 15,916,492 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-09-18 | 2020-09-22 | 0 | — | $0 | 5,314,100 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-09-18 | 2020-09-22 | 2,000 | $3.77 | $7.5K | 5,314,100 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-16 | 2020-09-16 | 125,000 | $0.16 | $20.0K | 16,016,492 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-16 | 2020-09-16 | 0 | — | $0 | 16,016,492 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-09-16 | 2020-09-16 | 100 | $3.75 | $375 | 5,312,100 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-09-16 | 2020-09-16 | 0 | — | $0 | 5,312,100 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-15 | 2020-09-16 | 0 | — | $0 | 16,141,492 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-15 | 2020-09-16 | 82,084 | $0.16 | $13.1K | 16,141,492 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | J Other deriv | 2020-09-14 | 2020-09-16 | 1,200,000 | — | $0 | 1,200,000 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | J Other deriv | 2020-09-14 | 2020-09-16 | 0 | — | $0 | 1,200,000 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-14 | 2020-09-16 | 0 | — | $0 | 16,223,576 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-14 | 2020-09-16 | 130,000 | $0.17 | $22.1K | 16,223,576 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-11 | 2020-09-11 | 0 | — | $0 | 16,353,576 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-11 | 2020-09-11 | 170,000 | $0.17 | $28.9K | 16,353,576 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-10 | 2020-09-11 | 282,500 | $0.17 | $48.0K | 16,523,576 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-10 | 2020-09-11 | 0 | — | $0 | 16,523,576 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-09 | 2020-09-11 | 550,570 | $0.18 | $99.1K | 16,806,076 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-09 | 2020-09-11 | 0 | — | $0 | 16,806,076 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-08 | 2020-09-08 | 0 | — | $0 | 17,356,826 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-08 | 2020-09-08 | 1,337,482 | $0.16 | $214.0K | 17,356,826 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-09-08 | 2020-09-09 | 8,543 | $1.46 | $12.5K | 2,019,995 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-09-08 | 2020-09-09 | 0 | — | $0 | 2,019,995 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-04 | 2020-09-08 | 114,000 | $0.16 | $18.2K | 18,694,308 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-04 | 2020-09-08 | 0 | — | $0 | 18,694,308 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-09-04 | 2020-09-09 | 100,000 | $2.20 | $220.0K | 30,014,285 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-09-04 | 2020-09-09 | 0 | — | $0 | 30,014,285 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-09-04 | 2020-09-09 | 0 | — | $0 | 2,011,452 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-09-04 | 2020-09-09 | 23,457 | $1.41 | $33.1K | 2,011,452 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-09-03 | 2020-09-03 | 0 | — | $0 | 1,987,995 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-09-03 | 2020-09-03 | 36,000 | $1.39 | $50.0K | 1,987,995 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-03 | 2020-09-08 | 53,479 | $0.16 | $8.6K | 18,808,308 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-09-03 | 2020-09-08 | 0 | — | $0 | 18,808,308 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-09-02 | 2020-09-03 | 20,000 | $1.47 | $29.4K | 1,951,995 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-09-02 | 2020-09-03 | 0 | — | $0 | 1,951,995 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-09-01 | 2020-09-03 | 0 | — | $0 | 1,931,995 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-09-01 | 2020-09-03 | 30,000 | $1.46 | $43.8K | 1,931,995 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-08-31 | 2020-08-31 | 35,000 | $0.11 | $3.9K | 18,861,787 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-08-31 | 2020-08-31 | 0 | — | $0 | 18,861,787 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-08-31 | 2020-08-31 | 20,000 | $1.45 | $29.0K | 1,901,995 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-08-31 | 2020-08-31 | 0 | — | $0 | 1,901,995 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-08-28 | 2020-08-31 | 75,000 | $0.11 | $8.3K | 18,896,787 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-08-28 | 2020-08-31 | 0 | — | $0 | 18,896,787 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-08-27 | 2020-08-31 | 55,263 | $0.12 | $6.6K | 18,971,787 | SEC↗ |
| CTDH Cyclo Therapeutics, Inc. | S Sale | 2020-08-27 | 2020-08-31 | 0 | — | $0 | 18,971,787 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-08-27 | 2020-08-31 | 12,000 | $1.50 | $18.0K | 1,881,995 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-08-27 | 2020-08-31 | 0 | — | $0 | 1,881,995 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-08-26 | 2020-08-26 | 12,000 | $1.50 | $18.0K | 1,869,995 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-08-26 | 2020-08-26 | 0 | — | $0 | 1,869,995 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-08-25 | 2020-08-26 | 17,211 | $1.53 | $26.3K | 1,857,995 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-08-25 | 2020-08-26 | 0 | — | $0 | 1,857,995 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-08-24 | 2020-08-26 | 5,692 | $1.47 | $8.4K | 1,840,784 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-08-24 | 2020-08-26 | 0 | — | $0 | 1,840,784 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-08-21 | 2020-08-21 | 116,242 | $1.44 | $167.4K | 1,835,092 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-08-21 | 2020-08-21 | 0 | — | $0 | 1,835,092 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-08-20 | 2020-08-20 | 2,000 | $3.40 | $6.8K | 5,312,000 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-08-20 | 2020-08-20 | 0 | — | $0 | 5,312,000 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-08-20 | 2020-08-21 | 124,472 | $1.53 | $190.4K | 1,718,850 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-08-20 | 2020-08-21 | 0 | — | $0 | 1,718,850 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-08-19 | 2020-08-20 | 0 | — | $0 | 5,309,000 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-08-19 | 2020-08-20 | 1,000 | $3.40 | $3.4K | 5,310,000 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-08-19 | 2020-08-20 | 0 | — | $0 | 5,310,000 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-08-19 | 2020-08-20 | 998 | $3.05 | $3.0K | 5,309,000 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-08-19 | 2020-08-21 | 0 | — | $0 | 1,594,378 | SEC↗ |
| TENX TENAX THERAPEUTICS, INC. | P Buy | 2020-08-19 | 2020-08-21 | 70,767 | $1.45 | $102.6K | 1,594,378 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-08-18 | 2020-08-20 | 6,000 | $3.00 | $18.0K | 5,308,002 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-08-18 | 2020-08-20 | 0 | — | $0 | 5,308,002 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other deriv | 2020-07-28 | 2020-07-30 | 0 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other deriv | 2020-07-28 | 2020-07-30 | 2,063,334 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other deriv | 2020-07-28 | 2020-07-30 | 0 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other deriv | 2020-07-28 | 2020-07-30 | 2,130,493 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other deriv | 2020-07-28 | 2020-07-30 | 0 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other deriv | 2020-07-28 | 2020-07-30 | 0 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other deriv | 2020-07-28 | 2020-07-30 | 3,333,334 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other deriv | 2020-07-28 | 2020-07-30 | 1,430,493 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other | 2020-07-28 | 2020-07-30 | 1,419,507 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other | 2020-07-28 | 2020-07-30 | 0 | — | $0 | 0 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-07-17 | 2020-07-21 | 0 | — | $0 | 5,302,002 | SEC↗ |
| RSLS ReShape Lifesciences Inc. | P Buy | 2020-07-17 | 2020-07-21 | 4,500 | $3.00 | $13.5K | 5,302,002 | SEC↗ |
| VXRT Vaxart, Inc. | X Exercise deriv | 2020-06-29 | 2020-06-30 | 0 | — | $0 | 0 | SEC↗ |
| VXRT Vaxart, Inc. | X Exercise deriv | 2020-06-29 | 2020-06-30 | 4,090,909 | — | $0 | 0 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-06-29 | 2020-06-30 | 0 | — | $0 | 145,523 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-06-29 | 2020-06-30 | 9,385,386 | $8.29 | $77.80M | 145,523 | SEC↗ |
| VXRT Vaxart, Inc. | X Exercise | 2020-06-29 | 2020-06-30 | 0 | — | $0 | 9,530,909 | SEC↗ |
| VXRT Vaxart, Inc. | X Exercise | 2020-06-29 | 2020-06-30 | 4,090,909 | $1.10 | $4.50M | 9,530,909 | SEC↗ |
| VXRT Vaxart, Inc. | X Exercise deriv | 2020-06-26 | 2020-06-30 | 16,666,667 | — | $0 | 0 | SEC↗ |
| VXRT Vaxart, Inc. | X Exercise deriv | 2020-06-26 | 2020-06-30 | 0 | — | $0 | 0 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-06-26 | 2020-06-30 | 0 | — | $0 | 5,440,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-06-26 | 2020-06-30 | 18,226,667 | $10.38 | $189.19M | 5,440,000 | SEC↗ |
| VXRT Vaxart, Inc. | X Exercise | 2020-06-26 | 2020-06-30 | 0 | — | $0 | 23,666,667 | SEC↗ |
| VXRT Vaxart, Inc. | X Exercise | 2020-06-26 | 2020-06-30 | 16,666,667 | $0.30 | $5.00M | 23,666,667 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-06-11 | 2020-06-11 | 28,000 | $2.44 | $68.3K | 1,128,000 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-06-09 | 2020-06-11 | 267,806 | $2.52 | $674.9K | 1,100,000 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-06-09 | 2020-06-11 | 0 | — | $0 | 29,914,285 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2020-06-09 | 2020-06-11 | 1,753,680 | $2.50 | $4.38M | 29,914,285 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-06-03 | 2020-06-03 | 0 | — | $0 | 7,000,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-06-03 | 2020-06-03 | 400,000 | $2.77 | $1.11M | 7,000,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-06-02 | 2020-06-03 | 0 | — | $0 | 7,400,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-06-02 | 2020-06-03 | 800,000 | $2.75 | $2.20M | 7,400,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-06-01 | 2020-06-03 | 200,000 | $2.74 | $548.0K | 8,200,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-06-01 | 2020-06-03 | 0 | — | $0 | 8,200,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-27 | 2020-05-29 | 0 | — | $0 | 8,400,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-27 | 2020-05-29 | 200,000 | $2.61 | $522.0K | 8,400,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-22 | 2020-05-22 | 200,000 | $2.86 | $572.0K | 8,600,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-22 | 2020-05-22 | 0 | — | $0 | 8,600,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-21 | 2020-05-22 | 400,000 | $2.97 | $1.19M | 8,800,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-21 | 2020-05-22 | 0 | — | $0 | 8,800,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-20 | 2020-05-22 | 0 | — | $0 | 9,200,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-20 | 2020-05-22 | 1,150,000 | $3.19 | $3.67M | 9,200,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-18 | 2020-05-18 | 650,000 | $2.86 | $1.86M | 10,350,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-18 | 2020-05-18 | 0 | — | $0 | 10,350,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-15 | 2020-05-18 | 0 | — | $0 | 11,000,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-15 | 2020-05-18 | 458,639 | $2.82 | $1.29M | 11,000,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-14 | 2020-05-18 | 0 | — | $0 | 11,458,639 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-14 | 2020-05-18 | 834,669 | $3.02 | $2.52M | 11,458,639 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-13 | 2020-05-13 | 0 | — | $0 | 12,293,308 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-13 | 2020-05-13 | 525,616 | $2.97 | $1.56M | 12,293,308 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-12 | 2020-05-13 | 0 | — | $0 | 12,818,924 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-12 | 2020-05-13 | 1,581,076 | $3.02 | $4.77M | 12,818,924 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-11 | 2020-05-13 | 1,300,000 | $2.79 | $3.63M | 14,400,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-11 | 2020-05-13 | 0 | — | $0 | 14,400,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-08 | 2020-05-08 | 100,000 | $2.52 | $252.0K | 15,700,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-08 | 2020-05-08 | 0 | — | $0 | 15,700,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-07 | 2020-05-08 | 0 | — | $0 | 15,800,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-07 | 2020-05-08 | 100,000 | $2.51 | $251.0K | 15,800,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-06 | 2020-05-08 | 0 | — | $0 | 15,900,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-06 | 2020-05-08 | 50,000 | $2.58 | $129.0K | 15,900,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-05 | 2020-05-05 | 0 | — | $0 | 15,950,000 | SEC↗ |
| VXRT Vaxart, Inc. | S Sale | 2020-05-05 | 2020-05-05 | 692,531 | $2.66 | $1.84M | 15,950,000 | SEC↗ |